Skyrizi 19558594

GUDID 48054083023968

The 1.2mL Skyrizi On-Body Injector is designed to be used in conjunction with a pre-filled cartridge assembly containing a 180mg/1.2mL dose of risankizumab-rzaa drug product. The single use device is designed for subcutaneous injection. The device is pre-sterilized and pre-programmed. The device is co-packaged with the drug product and is not marketed separately.

ABBVIE INC.

Subcutaneous self-injection aid
Primary Device ID48054083023968
NIH Device Record Key819d364d-0755-49be-a33e-186b0469ba3a
Commercial Distribution StatusIn Commercial Distribution
Brand NameSkyrizi
Version Model Number19558594
Catalog Number19558594
Company DUNS078458370
Company NameABBVIE INC.
Device Count1
DM Exemptfalse
Pre-market Exemptfalse
MRI Safety StatusMR Unsafe
Human Cell/Tissue Productfalse
Device Kitfalse
Device Combination Productfalse
Single Usetrue
Lot Batchtrue
Serial Numbertrue
Manufacturing Datetrue
Expiration Datefalse
Donation Id Numberfalse
Contains Natural Rubber Latexfalse
Labeled No Natural Rubber Latextrue
RX Perscriptiontrue
OTC Over-The-Counterfalse

Device Dimensions

Width41 Millimeter
Length85 Millimeter
Height22.5 Millimeter
Width41 Millimeter
Length85 Millimeter
Height22.5 Millimeter
Width41 Millimeter
Length85 Millimeter
Height22.5 Millimeter
Width41 Millimeter
Length85 Millimeter
Height22.5 Millimeter

Operating and Storage Conditions

Storage Environment TemperatureBetween 2 Degrees Celsius and 28 Degrees Celsius
Special Storage Condition, SpecifyBetween 0 and 0 *Store in cartons until time of use. Storage Relative Humidity 15-90%, non-condensing and storage pressure 61.7-106kPa
Storage Environment TemperatureBetween 2 Degrees Celsius and 28 Degrees Celsius
Special Storage Condition, SpecifyBetween 0 and 0 *Store in cartons until time of use. Storage Relative Humidity 15-90%, non-condensing and storage pressure 61.7-106kPa
Storage Environment TemperatureBetween 2 Degrees Celsius and 28 Degrees Celsius
Special Storage Condition, SpecifyBetween 0 and 0 *Store in cartons until time of use. Storage Relative Humidity 15-90%, non-condensing and storage pressure 61.7-106kPa
Storage Environment TemperatureBetween 2 Degrees Celsius and 28 Degrees Celsius
Special Storage Condition, SpecifyBetween 0 and 0 *Store in cartons until time of use. Storage Relative Humidity 15-90%, non-condensing and storage pressure 61.7-106kPa

Device Identifiers

Device Issuing AgencyDevice ID
GS148054083023968 [Primary]

FDA Product Code

QLFOn-Body Injector

Sterilization

Steralize Prior To Usetrue
Device Is Steriletrue

[48054083023968]

Ethylene Oxide


[48054083023968]

Ethylene Oxide


[48054083023968]

Ethylene Oxide


[48054083023968]

Ethylene Oxide


Device Entry Metadata

Public Version StatusNew
Device Record StatusPublished
Public Version Number1
Public Version Date2022-12-15
Device Publish Date2022-12-07

On-Brand Devices [Skyrizi]

48054083023234The 2.4mL Skyrizi On-Body Injector is designed to be used in conjunction with a pre-filled cartr
48054083023968The 1.2mL Skyrizi On-Body Injector is designed to be used in conjunction with a pre-filled cartr

Trademark Results [Skyrizi]

Mark Image

Registration | Serial
Company
Trademark
Application Date
SKYRIZI
SKYRIZI
87320935 5857879 Live/Registered
AbbVie Biotechnology Ltd.
2017-02-01

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.